tatives of those responsible for the training of
specialists in the speciaity of Chemical
Biopathology.
1.5 The Chemical Commission of the Specialist
Section of Medical Biopathology coliabarates
closely with recognised national bodies to
initiale and maintain a system of manpower
planning for the speciaity of Chemical
Biopathology.
Artide 2
GENERAL ASPECTS of TRAINING in
Chemical Biopathology
2.1 The aim of the training is to produce trained
Chemical Biopathologists to provide specia–
list opinion in his/her clinical discipline and
who should have developed the appropriate
management skills to lead a department.
2.1 Selection of trainees and their access to
training in Chemical Biopathology should be
competitive.
2.2 The minimum duration of training in
Chemical Biopathology should be 5 years
including one year of clinical practice
(outside the Medical Biopathology Depart–
ment) gained after obtaining licence to
practice as a doctor.
2.3 The Chemical Commission of the Specialist
Section of Medical Biopathology recom–
mends that a common trunk of training in
Medical Biopathology should be a period of
one year (within the Medical Biopathology
Department). During this period experience in
the fields of molecular biology, immunoche–
mistry, statistics, quality assurance, informa–
tion technology and management and commu–
nicative skills would be obtained.
2.4 Programmes to cover the training require–
ments for the speciaity should be available to
all trainers and trainees. The Specialist
Section recommends the use of logbooks by
trainees, which should be contirmed by
trainers.
2.5 The Chemical Commission of the Specialist
Section of Medical Biopathology proposes to
establish a system of quality assurance and
assessment of training in the speciaity (see
1.3. and 1.4.).
Klinisk Kjemi
i
Norden 4, 2001
2.6 The Chemical Commission of the Specialist
Section of Medical Biopathology supports
the existing arrangements in the European
Union countries to control entry into the
trammg grades. Manpower planning
policies are limited by the lack of adequate
data (see 1.5.).
2.7 The Specialist Section supports the ad hoc
arrangements that are currently available in
most European Union countries for the arran–
gement of training in other countries. More
formal arrangements are limited by the lack of
financial support which trainees require
during such periods.
2.8 General objectives of the training:
a Knowledge in the anatomy, physiology,
biochemistry and pathophysiology of human
organ systems above the basic knowledge
acquired after medical studies.
b Comprehensive knowledge of the pathogenetic
mechanisms and natural history and epide–
miology of those diseases common!y diagnosed
and monitored by Chemical Biopathology.
c Knowledge of the most common Biochemical
tests and organ function tests used in medical
practice including; indications for ordering the
tests, the Biochemical and physical/Bioche–
mical principles of the measurement process
and the pre- and post-analytical preeautians to
be taken.
d Interpretative skills in order that a clinically
useful opinion can be derived from laboratory
data and other relevant medical data which
he/she, as a consultant, can effectively commu–
nicate to colleagues by consultation.
e Technical knowledge gained from the close
acquaintance with laboratory methods, so that
the most efficient technology appropriate to a
clinical problem can be chosen, and that proce–
dures for quality control and quality assurance
can be implemented. Trainees should be
familiar with the European and other standards
for laboratory quality systems.
f The trainee should be able to develop new
research protocols and interpret research data.
He/she should be capable of collecting and
evaluating organised scientific knowledge and
share it orally or in written form.
19
